CTC Bio Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 257

Employees

  • Stock Symbol
  • 060590

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $4.62
  • (As of Monday Closing)

CTC Bio General Information

Description

CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

Contact Information

Website
www.ctcbio.com
Formerly Known As
World Livestock
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 901, Tower A, Geumgangpenterium IX Tower
  • 27, Dongtancheomdansaneop 1-ro
  • Hwaseong-si, Gyeonggi-do
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Agricultural Chemicals
Stock Exchange
KRX
Vertical(s)
Manufacturing, AgTech, Supply Chain Tech, TMT, Life Sciences
Corporate Office
  • 901, Tower A, Geumgangpenterium IX Tower
  • 27, Dongtancheomdansaneop 1-ro
  • Hwaseong-si, Gyeonggi-do
  • South Korea
+82

CTC Bio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CTC Bio Stock Performance

As of 14-Jul-2025, CTC Bio’s stock price is $4.62. Its current market cap is $110M with 23.9M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.62 $4.66 $4.19 - $6.72 $110M 23.9M 30.7K -$0.13

CTC Bio Financials Summary

As of 31-Mar-2025, CTC Bio has a trailing 12-month revenue of $104M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 121,674 115,617 206,031 131,644
Revenue 104,171 105,836 105,456 127,856
EBITDA 3,727 2,390 (5,541) 7,393
Net Income (3,084) (3,826) (11,922) 3,640
Total Assets 101,137 104,339 128,707 147,537
Total Debt 21,996 22,315 27,384 31,640
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CTC Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CTC Bio‘s full profile, request access.

Request a free trial

CTC Bio Patents

  • 117

    Total Documents Applications and Grants

  • Total Patents Families

  • 64

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

CTC Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3150011-A1 Intraoral fast disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation Pending 09-Aug-2019
EP-4011366-A1 Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation Pending 09-Aug-2019
EP-4011366-A4 Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation Pending 09-Aug-2019
US-20230073516-A1 Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation Inactive 09-Aug-2019
CA-3089821-A1 Capsule filling apparatus Active 02-Feb-2018 A61J3/074
To view CTC Bio’s complete patent history, request access »

CTC Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CTC Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CTC Bio‘s full profile, request access.

Request a free trial

CTC Bio Investments & Acquisitions (2)

CTC Bio’s most recent deal was a Corporate Asset Purchase with SK Chemical (Ansan Plant). The deal was made on 01-Sep-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SK Chemical (Ansan Plant) 01-Sep-2014 Corporate Asset Purchase Buildings and Property
LG Life Sciences (Animal Drug Business) 01-Apr-2007 Merger/Acquisition Pharmaceuticals
To view CTC Bio’s complete investments and acquisitions history, request access »

CTC Bio FAQs

  • When was CTC Bio founded?

    CTC Bio was founded in 1993.

  • Where is CTC Bio headquartered?

    CTC Bio is headquartered in Hwaseong-si, South Korea.

  • What is the size of CTC Bio?

    CTC Bio has 257 total employees.

  • What industry is CTC Bio in?

    CTC Bio’s primary industry is Biotechnology.

  • Is CTC Bio a private or public company?

    CTC Bio is a Public company.

  • What is CTC Bio’s stock symbol?

    The ticker symbol for CTC Bio is 060590.

  • What is the current stock price of CTC Bio?

    As of 14-Jul-2025 the stock price of CTC Bio is $4.62.

  • What is the current market cap of CTC Bio?

    The current market capitalization of CTC Bio is $110M.

  • What is CTC Bio’s current revenue?

    The trailing twelve month revenue for CTC Bio is $104M.

  • What is CTC Bio’s annual earnings per share (EPS)?

    CTC Bio’s EPS for 12 months was -$0.13.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »